BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Massanella M, Puthanakit T, Leyre L, Jupimai T, Sawangsinth P, de Souza M, Suntarattiwong P, Kosalarksa P, Borkird T, Kanjanavanit S, Chokephaibulkit K, Hansudewechakul R, Petdachai W, Mitchell JL, Robb ML, Trautmann L, Ananworanich J, Chomont N; RV474/HIVNAT194 and RV475/HIVNAT 209 Study Groups. Continuous Prophylactic Antiretrovirals/Antiretroviral Therapy Since Birth Reduces Seeding and Persistence of the Viral Reservoir in Children Vertically Infected With Human Immunodeficiency Virus. Clin Infect Dis 2021;73:427-38. [PMID: 32504081 DOI: 10.1093/cid/ciaa718] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Katusiime MG, Van Zyl GU, Cotton MF, Kearney MF. HIV-1 Persistence in Children during Suppressive ART. Viruses 2021;13:1134. [PMID: 34204740 DOI: 10.3390/v13061134] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Ajibola G, Garcia-Broncano P, Maswabi K, Bennett K, Hughes MD, Moyo S, Mohammed T, Jean-Philippe P, Sakoi M, Batlang O, Lockman S, Makhema J, Kuritzkes DR, Lichterfeld M, Shapiro RL. Viral Reservoir in Early-Treated HIV-Infected Children and Markers for Sustained Viral Suppression. Clin Infect Dis 2021:ciab143. [PMID: 33605999 DOI: 10.1093/cid/ciab143] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Amin O, Powers J, Bricker KM, Chahroudi A. Understanding Viral and Immune Interplay During Vertical Transmission of HIV: Implications for Cure. Front Immunol 2021;12:757400. [PMID: 34745130 DOI: 10.3389/fimmu.2021.757400] [Reference Citation Analysis]
4 Powell L, Dhummakupt A, Siems L, Singh D, Le Duff Y, Uprety P, Jennings C, Szewczyk J, Chen Y, Nastouli E, Persaud D. Clinical validation of a quantitative HIV-1 DNA droplet digital PCR assay: Applications for detecting occult HIV-1 infection and monitoring cell-associated HIV-1 dynamics across different subtypes in HIV-1 prevention and cure trials. J Clin Virol 2021;139:104822. [PMID: 33930698 DOI: 10.1016/j.jcv.2021.104822] [Reference Citation Analysis]
5 Payne H, Chan MK, Watters SA, Otwombe K, Hsiao NY, Babiker A, Violari A, Cotton MF, Gibb DM, Klein NJ. Early ART-initiation and longer ART duration reduces HIV-1 proviral DNA levels in children from the CHER trial. AIDS Res Ther 2021;18:63. [PMID: 34587974 DOI: 10.1186/s12981-021-00389-1] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Dhummakupt A, Persaud D. Insights from Clonal Expansion and HIV Persistence in Perinatal Infections. mBio 2021;12:e0098321. [PMID: 34425702 DOI: 10.1128/mBio.00983-21] [Reference Citation Analysis]
7 Dhummakupt A, Persaud D. Capitalizing on Postexposure Antiretroviral Prophylaxis to Restrict Seeding of the Human Immunodeficiency Virus Reservoir. Clin Infect Dis 2021;73:439-40. [PMID: 32503043 DOI: 10.1093/cid/ciaa715] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]